Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine in Immune Related Arthritis or Arthralgias
NCT04354649Phase 2Recruiting
- Sponsor
- American Health Staffing Group
- Start
- Sep 2021
- Primary completion
- Jul 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in autoimmune arthritis and arthralgia comparing Hydroxychloroquine + Prednisone with Placebo + Prednisone (2 arms). Primary endpoint: Recurrence of grade >=2 Immune-Related Arthritis or Arthralgia at 1 year. Started Sep 2021; status: recruiting.
02
Drugs
hydroxychloroquine
03
Conditions
autoimmune arthritisarthralgia
Beyond the preview
Go deeper on NCT04354649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04354649.